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Data from experiments conducted almost exclusively in the rat
have established that some phthalates have deleterious effects on
the fetal testis probably due to their antiandrogenic and/or
estrogenic effects, but their mechanisms of action remain
unknown. A recent study reported that phthalates also have
deleterious effects on human fetal testis with germ cell number,
but not steroidogenesis altered. Therefore, we used organ culture
of fetal testes at different stages of development to analyze the
direct effects of phthalates on both steroidogenesis and gonocyte
development and to determine if the effects of MEHP on these
functions reported in the rat can be extended to other mammalian
species. We defined specific periods of sensitivity of the fetal
mouse testis to MEHP for these two functions and showed that the
effects of phthalates on steroidogenesis vary with the develop-
mental stage. Conversely, the strong deleterious effects of
phthalates on germ cells were constantly present during the
active phases of gonocyte development and thus share no
relationship with the steroidogenic status. Moreover, all the effects
of phthalates were unchanged in testes from mice deficient for
estrogen (ERaKO or ERbKO) or androgen (Tfm) receptors. In
conclusion, our results demonstrate that phthalates impair mouse
fetal germ cell number similarly to other mammalian species, but
are neither estrogenic nor antiandrogenic molecules because their
effects do not involve, directly or indirectly, ER or AR.
Key Words: MEHP; phthalates; fetal testis; gonocytes;
steroidogenesis; Leydig cell; development; estrogen receptor;
androgen receptor.
Phthalate esters are a class of environmental endocrine
disrupting chemicals which are mainly used as plasticizers in
PVC plastics. They are found in numerous consumer goods
and, because they are not covalently bound to the plastic
product, they can leach out over time from these products and
can be ingested (Silva et al., 2004). After absorption, phthalates
are rapidly hydrolyzed by esterases in the gut and other tissues
into a monoester, which is the active molecule (Latini, 2005).
For example, di-(2-ethylhexyl) phthalate (DEHP), one of the
most widely used phthalates, is metabolized to its monoester
metabolite, mono-(2-ethylhexyl) phthalate (MEHP), which is
a recognized active testicular toxicant (Fisher, 2004).
Numerous studies in the rat have shown that in utero
exposure to phthalates results in male reproductive disorders
including altered seminiferous cord formation, multinucleated
gonocyte (MNG) formation, epididymal agenesis, nipple
retention, reduced ano-genital distance, hypospadias and
cryptorchidism (Foster, 2006; Gray et al., 2006), and also
reduction of fetal testosterone production and Leydig cell Insl3
gene expression (Lehmann et al., 2004; McKinnell et al., 2005;
Sharpe and Skakkebaek, 2008), all these effects attesting to
a profound alteration of testis development.
During fetal and neonatal development of the testis (Jost and
Magre, 1993; Olaso and Habert, 2000), after migration of the
primordial germ cells (PGCs) from extra-embryonic mesoderm
to the genital ridge at embryonic day 11.5 (E11.5) in the mouse
(Yoshimizu et al., 2001), the differentiating Sertoli cells
(Wilhelm et al., 2007) surround the germ cells, therefore called
gonocytes, to form the seminiferous cords from E12.5. The
gonocytes divide actively, many of them undergoing apoptosis
by E12.5-14.5 (Wang et al., 1998) and then enter a quiescent
period (Nagano et al., 2000; Vergouwen et al., 1991). After
birth, they resume mitosis while a second wave of apoptosis
occurs (Boulogne et al., 2003; Wang et al., 1998) (Fig. 1) and
start to differentiate into spermatogonia. The interstitial region
contains mesenchymal cells and steroid-secreting Leydig cells
from E12.5 (Livera et al., 2006; O’Shaughnessy et al., 2005).
Interactions between the different cell lineages occur early in
morphogenesis of the testis and are crucial for its normal
development. Androgens mediate a wide range of develop-
mental and physiological responses that are critical for the male
reproductive and nonreproductive system (Sharpe, 2006;
Welsh et al., 2008). During fetal life, testis development is
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physiologically modulated by, among other factors (Olaso and
Habert, 2000), estrogen and androgen because estrogen
receptor beta (ERb) and androgen receptor (AR) inactivation
lead to an increase in germ cell number (Delbes et al., 2004;
Merlet et al., 2007), whereas testosterone production is
enhanced by ERa inactivation (Delbes et al., 2005).
Until now, the mechanisms of action of phthalates have not
been elucidated. MEHP activates peroxisome proliferators–
activated receptor (PPAR-a) in cell transactivation assays
(Corton and Lapinskas, 2005) but phthalate-treated PPAR-
a/ mice develop toxic lesions in the testis (Ward et al.,
1998), suggesting that phthalates can act through PPAR-
a–independent pathways in mediating testicular toxicity
(Bhattacharya et al., 2005). In addition, phthalates show little
estrogenic activity (Harris et al., 1997; Takeuchi et al., 2005),
but can also reduce estradiol production (Lovekamp-Swan and
Davis, 2003), and there is a growing consensus that they are
antiandrogenic (Hu et al., 2009). However, phthalates and their
mono-phthalate metabolites do not bind to AR (Parks et al.,
2000), indicating that they are not direct AR antagonists. Most
studies investigating the in utero effects of phthalates have
been performed in the rat in vivo and have focused on the
phthalate-induced suppression of testosterone production and
Leydig cell aggregation (Fisher et al., 2003; Mylchreest et al.,
1999). This has led to a hypothesized causal relationship
between reduced testosterone production, altered fetal testicular
development and reduced sperm counts in adulthood (Scott
et al., 2007; Skakkebaek et al., 2001). However, an in vitro
study from our laboratory on human fetal testis evidenced
a reduction of the number of gonocytes by MEHP in the
absence of any alteration of testosterone production (Lambrot
et al., 2009). A recent study in the mouse demonstrated also
that, as in the rat, in utero DBP exposure increases the number
of MNGs, but unlike the rat this response occurs in the absence
of measurable disruption of testicular testosterone concen-
trations (Gaido et al., 2007).
Therefore, we used organ culture of fetal mouse testis to
establish that there is no relationship between phthalate-
induced alterations of fetal steroidogenesis and gonocyte
development, unlike what has been concluded from observa-
tions in the rat. Furthermore, using mice deficient for AR or
ER, we showed that the phthalate-induced alterations are
independent of these receptors.
MATERIAL AND METHODS
Chemicals and solutions. The culture medium was phenol red-free
Dulbecco’s Modified Eagle Medium/Ham F12 (1:1) (Invitrogen, Carlsbad,
CA) supplemented with 80 lg/ml gentamicin (Invitrogen). Ovine LH (oLH;
NIH.LH S19; 1.01 IU/mg) was a gift from Dr A.F. Parlow (National Institute of
Diabetes and Digestive and Kidney Diseases, Bethesda, MD). MEHP was from
TCI Europe (Antwerp, Belgium). A stock solution (4mM) was made up in
dimethyl sulfoxide and then diluted in culture medium. db-cAMP (N6, 2#-O-
dibutyryl-cAMP) was from Sigma Aldrich (St Louis, MO).
Animals. C57Bl/6 and transgenic mice were housed under controlled
photoperiod (lights on 08:00-20:00) with ad libitum access to tap water and
a soy and alfalfa-free breeding diet (Global diet 2019, Harlan Teklad,
Indianapolis, IN). Mice lacking ERa (ERa/) or ERb (ERb/) were
produced by Dupont et al. (2000) and generously provided by Pierre Chambon
(Institut de Genetique et de Biologie Moleculaire et Cellulaire, Illkirch, France).
Androgen-insensitive Tfm mice (C57BL/6J-Aw-J.Cg-EdaTa-6J_/_ArTfm, Tfm/
Y) were from the Jackson Laboratory (Bar Harbor, ME). Transgenic animals
were genotyped as described previously (Delbes et al., 2004, 2005; Merlet
et al., 2007). Males were caged with females overnight and the day following
overnight mating was counted as E0.5. Pregnant mice were killed by cervical
dislocation on E13.5, E15.5, or E18.5 and the fetuses were quickly removed
from the uterus. Fetuses were dissected under a binocular microscope, their sex
was determined on the basis of the gonad morphology and the testes were
collected from male fetuses. All animal studies were conducted in accordance
with the NIH Guide for Care and Use of Laboratory Animals.
Organ culture and treatment. Organ cultures were performed as
previously described (Livera et al., 2006). Briefly, intact E13.5 testes associated
with their mesonephros were placed on 10-mm-diameter Millicell CM filters
(Millipore, Billerica, MA) (pore size 0.45 lm). Testes from E15.5 and E18.5
were isolated and cut into six and eight pieces, respectively, and all the pieces
from the same testis were placed on a single Millicell filter. The filter bearing
the pieces of testes was floated on 0.4 ml of culture medium in tissue culture
dishes and incubated at 37C, in humidified atmosphere containing 95% air/5%
CO2. The medium was changed every 24 h and the culture was pursued for 1 or
3 days at E13.5 and for 3 days at E15.5 and E18.5 (Fig. 1). The testes were
cultured in the presence or absence of oLH (100 ng/ml) and the effect of 20 or
200lM MEHP was estimated by comparing one testis cultured in the presence
of MEHP with the other testis from the same fetus cultured in control medium.
At the end of culture, testes were fixed for 1 h at room temperature in Bouin’s
fluid, embedded in paraffin, and cut into 5-lm sections. For RNA analysis,
testes were immediately dry frozen with liquid nitrogen and stored at 80C.
The entire media were kept at 20C until testosterone radioimmunoassay. The
data were obtained from at least three independently repeated cultures with
fetuses from different litters.
Immunohistochemistry. Serial sections were mounted on slides, deparaffi-
nized and rehydrated. They were immunostained by a standard procedure as
previously described (Delbes et al., 2007). To unmask the MVH (mouse vasa
homolog) protein, sections were microwaved at 750 W for 5 min and at 450W
for 3 min in 10mM citrate buffer solution (pH 6.0). For all immunohistological
procedures, slides were incubated in 0.3% H2O2 for 15 min and in 5% bovine
serum albumin in phosphate-buffered saline for 30 min to block nonspecific
antigens and were then incubated with the primary antibody (rabbit polyclonal
anti-AMH (anti-Mu¨llerian hormone) antibody (1/500; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA), the rabbit polyclonal anti-3bHSD antibody (1/5000;
provided by Prof A. Payne, Stanford University Medical Center) or the rabbit
anti-MVH antibody (1/500; Abcam, Cambridge, UK) overnight at 4C. The
primary antibody was detected by incubation with an appropriate biotinylated
secondary antibody (1:200; Vector Laboratories, Burlingame, CA) for a further
30 min at room temperature followed by incubation with avidin-biotin-
peroxidase complex (Vector Laboratories) for 30 min. DAB (Vector
Laboratories) was used as the chromogen and hematoxylin as the nuclear
counterstained. Negative controls were done by omitting the primary antibody.
FIG. 1. Schematic representation of the development of gonocytes during
mouse fetal and neonatal life in relation to the timing and duration of the organ
cultures as described in ‘‘Material and Methods.’’
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Testicular cell counting. Germ cells and Leydig cells were identified by
immunohistochemical detection of MVH and 3bHSD, respectively. The
counting was done as previously described (Delbes et al., 2004). All counts
were performed blind using Histolab analysis software (Microvision Instru-
ments, Evry, France).
Measurement of germ cell apoptosis. Because cleaved caspase-3 is
involved in most of the apoptotic pathway, we chose its detection as a marker
of apoptosis (Delbes et al., 2004). Gonocytes were distinguished by combining
staining for AMH (a Sertoli-specific marker) and cleaved caspase-3 (rabbit
polyclonal anti-cleaved caspase-3 1:100; Cell Signaling Technology, Beverly,
MA). Cleaved caspase-3 was localized first using DAB (Vector Laboratories)
and AMH was then detected using VIP substrate (Vector Laboratories). The
percentage of apoptotic gem cells was determined by counting the stained and
unstained gonocytes in all sections mounted.
Measurement of BrdU incorporation index. The percentage of germ cells
in S-phase was evaluated by measuring the BrdU (5-bromo-2#-deoxyuridine)
incorporation by immunohistochemical methods using the Cell Proliferation
Kit (GE Healthcare, Buckinghamshire, UK) according to the manufacturer’s
recommendations. BrdU (1%) was added to the culture medium 3 h before the
end of culture. BrdU incorporation into proliferating cells was detected by
immunochemistry using a mouse anti-BrdU antibody and a peroxidase-linked
anti-mouse IgG. Sertoli cells and gonocytes were distinguished by combining
staining for AMH (a Sertoli-specific marker) and BrdU. BrdU localization was
performed first using DAB (Vector Laboratories) and AMH was then detected
using VIP substrate (Vector Laboratories). The BrdU incorporation index was
obtained by a blind counting of at least 1000 Sertoli cell or 400 gonocyte
stained and unstained nuclei in five nonconsecutive sections from every
treatment group experiment. Histolab analysis software was used for counting
(Microvision Instruments, Evry, France).
Measurement of testosterone production. Testosterone secretion into the
medium was determined in duplicate by direct radioimmunoassay, without
extraction as previously described (Habert and Picon, 1984).
RNA extraction and reverse transcription. Total RNA was extracted
using the RNeasy Plus mini-Kit (Qiagen, Courtaboeuf, France) and reverse
transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Courtaboeuf, France) according to the manufacturer’s instructions.
Real-time quantitative PCR. Q-PCRs were performed on an ABI PRISM
7000 Sequence Detector System using a TaqMan PCR Master Mix (Applied
Biosystems). The primers and probes used were assays on demand designed by
Applied Biosystems (Table 1). The primers and probes used for 3bHSD and
external standard luciferase were described (Baker and O’Shaughnessy 2001;
Merlet et al., 2007). Q-PCR was performed and analyzed as previously
described (Merlet et al., 2007). Results were analyzed by using the delta-delta
Ct method with the use of luciferase as a normalized control (Merlet et al.,
2007). For each treatment, the mRNA levels were determined in samples from
three different litters and at least from six to nine testes.
Statistical analysis. All values are expressed as means ± SEM. The
statistical significance of the difference between the mean values for the treated
and untreated testes from the same fetus was evaluated using the paired
Student’s t-test. The unpaired Student’s t-test was used to evaluate the
difference between the mean values for two different genotypes.
RESULTS
Effects of MEHP on Leydig Cells
Basal and LH-stimulated testosterone production. In wild-
type control testes, as shown in Figure 2, the presence of
200lM MEHP during 3 days of culture in basal medium
induced a high and significant time-dependent stimulation of
testosterone production in E13.5 and E18.5 testes. When the
testes were cultured in the presence of 100 ng/ml oLH,
testosterone production was increased fourfold in E13.5 testes
and more than 10-fold in E18.5 testes compared with basal
conditions. In these conditions, the daily testosterone pro-
duction in E13.5 testes was unaffected by 200lM MEHP, but
was significantly decreased in a time-dependent manner in
E18.5 testes with a strong inhibition on D3.
As expected (Delbes et al., 2005), testosterone production
was significantly higher in ERa/ animals than in respective
wild-type controls in basal conditions. The invalidation of ERa
did not modify the stimulatory and inhibitory effects of MEHP
on testosterone secretion in E18.5 testes in basal and LH-
stimulated conditions, respectively (Fig. 2).
Number of Leydig cells. Compared with controls, the
number of Leydig cells was not significantly modified after
exposure to 200lM MEHP in the presence or absence of LH at
all the studied stages (Fig. 3A). In addition, no abnormal
distribution or clustering of the Leydig cells was observed in
any condition (Fig. 3B).
Leydig cell gene expression. Because MEHP had no effect
on Leydig cell number, we hypothesized that its effect on
steroidogenesis was due to the modulation of the expression of
genes coding for proteins involved in cholesterol and testoster-
one biosynthesis or metabolism. Therefore, mRNA expression
of key genes was analyzed by real-time PCR (Fig. 4).
In basal conditions, significant increases in gene expression
likely to explain the stimulation of testosterone production by
MEHP were observed at the level of HMG-CoA reductase and
Cyp17a1 in E13.5 testes and StAR and Cyp17a1 in E18.5
testes (Fig. 4). In LH-stimulated conditions, the decrease in
testosterone production in E18.5 testes was related to a 40–
50% reduction of the expression levels of all the genes tested,
except 5-alpha-reductase, whereas they were not significantly
altered in E13.5 testes (Fig. 4) in agreement with the lack of
TABLE 1
Primers Used in Real-Time RT-PCR
Gene full name Gene symbol
Applied Biosystem
accession number
3-Hydroxy-3-methylglutaryl
coenzyme A reductase
HMG-CoA
reductase
Mm01282499_m1
Steroidogenic acute
regulatory protein
StAR Mm00441558_m1
P450 side-chain
cleavage enzyme
Cyp11a1 Mm 00490735_m1
P450 17 a hydroxylase Cyp17a1 Mm00484040_m1
Steroid 5-alpha reductase Srd5a1 Mm00614213_m1
P450 aromatase Cyp19a1 Mm00484049_m1
Luteinizing hormone
receptor (LH-R)
Lhcgr Mm00442931_m1
Insulin-like growth factor 3 Insl-3 Mm01340353_m1
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change in testosterone production. Aromatase (Cyp19a1) and
5-alpha-reductase are required in the conversion of testosterone
to estradiol and dihydrotestosterone, respectively, and could
modulate the amount of testosterone secreted. The expression
of aromatase was decreased in both the absence and presence
of LH at all ages studied (Fig. 4), but the expression of 5-alpha-
reductase was never modified. The expression of LH-R (LH
receptor, Lhcgr) in E13.5 and E18.5 testes was not modified by
MEHP in the absence of LH in the culture medium, but was
significantly reduced in its presence (Fig. 4). Interestingly, the
expression of Insl-3, the protein which plays a major role in
testis descent, was decreased by MEHP in all studied
conditions except in E13.5 testes cultured in the absence of
LH (Fig. 4).
db-cAMP–stimulated testosterone production. In an at-
tempt to elucidate whether the decrease in LH receptor
expression was involved in the inhibition of LH-stimulated
FIG. 2. Effect of MEHP on testosterone secretion by fetal testes from wild-type and ERa/ mice in organ culture. Testes at E13.5 (upper panels) and E18.5
(lower panels) were cultured for 3 days (D1–D3) in control medium or in the presence of 200lM MEHP. Cultures were performed in the absence (left panels) or
presence (right panels) of 100 ng/ml oLH as indicated. Values are mean ± SEM from 4 to 18 cultures. *p < 0.05, **p < 0.01, ***p < 0.001 versus corresponding
control value in the paired Student’s t-test. p < 0.05 in the unpaired Student’s t-test for different genotypes.
FIG. 3. Effect of MEHP on the number and histological appearance of Leydig cells in mouse testes in organ culture. (A) Number of Leydig cells in E13.5 and
E18.5 testes after 3 days of culture in the absence (white bars) or presence of 200lM MEHP (black bars) and in the absence or presence of 100 ng/ml oLH. Values
are mean ± SEM from four to five cultures. There was no significant difference between control and MEHP. (B) Leydig cells (arrows), as revealed by
immunostaining of 3b-HSD, in mouse testes at E18.5 after 3 days of culture in control medium or in the presence of 200lM MEHP. No morphological alteration or
distribution was detectable after MEHP exposure.
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testosterone production by MEHP at E18.5, we evaluated the
effect of MEHP on db-cAMP–stimulated testosterone pro-
duction. The inhibition of testosterone production by MEHP
(Fig. 5) was similar to that obtained with LH, which means
that it exerts its rate-limiting inhibitory effect downstream from
LH-R.
Effects of MEHP on Sertoli Cell Proliferation and Function
MEHP did not alter the proliferation of Sertoli cells because
the BrdU-labeling index was not modified after 3-day treatment
with 200lM MEHP at any age studied (results not shown).
However, immunostaining of AMH clearly showed that its
Sertoli cell content was markedly decreased compared with
control in E13.5, E15.5, and E18.5 testes after 3 days of
treatment with 200lM MEHP (Fig. 6).
Effects of MEHP on Germ Cells
Gonocyte distribution and morphology. After 3 days of
culture, the integrity of the seminiferous cord structure was
maintained in both control and treated testes at all fetal and
neonatal stages studied and at all concentrations of MEHP
tested (Fig. 7). However, with 200lM MEHP all the gonocyte
have disappeared in E13.5dpc testes (see further) and, in E15.5
and E18.5 testes, the gonocytes stayed aggregated in the center
of the cord (Figs. 6E and 6F).
MNGs occurred spontaneously in E15.5 and E18.5 control
testes after 3 days of culture, that is, during and after the
quiescent period, and their number was increased significantly
by 200lM MEHP with the greatest increase observed in E18.5
testes (Fig. 7A). E18.5 testes from ERb (ERb/) or AR (Tfm)
deficient mice, showed similar increase in MNCs (for ERb/:
1.84 ± 0.33% in control vs. 8.79 ± 0.94 in MEHP treated, n¼ 9;
for Tfm: 2.15 ± 0.52% in control vs. 12.5 ± 2.91 in MEHP
treated, n ¼ 4) than the wild-type (Fig. 7A: 2.02 ± 0.32% in
control vs. 8.79 ± 0.89 in MEHP treated, n¼ 9). In E13.5 testes,
no MNG was detected after 1 or 3 days of culture in control
conditions or after 24-h treatment with 20lM MEHP (Fig. 7A).
Number of gonocytes. Because MEHP affected testosterone
production differently in the presence and absence of LH, we
evaluated its effect on gonocytes in these two conditions
(Fig. 7B). The presence of LH and, consequently, a high level of
testosterone production, did not modify the number of
gonocytes in E13.5 and E18.5 control cultures. In contrast,
MEHP severely reduced the number of gonocytes in any
condition at all the stages studied, except with E15.5 testes
cultured for 3 days i.e. during the quiescent period. At E13.5, the
gonocytes had completely disappeared after 3 days of culture
(D3) in the presence of 200lM MEHP and the number of
gonocytes was reduced by 40% by 20lM MEHP after one day
of culture (D1). With E18.5 testes, 200lM MEHP reduced the
FIG. 4. Quantitative real-time PCR analysis of the effect of MEHP
(200lM) on mRNA levels of a selected set of genes involved in Leydig cell
cholesterol metabolism and steroidogenesis, of LH-R (Lhcgr) and Insl3 genes
in E13.5 (white bars) and E18.5 (black bars) testes after 3 days of culture in the
absence (A) or presence (B) of 100 ng/ml oLH. The results were calculated by
the delta-delta Ct method using an external standard (luciferase) added during
RNA extraction as an endogenous reference. The levels of mRNA are
expressed as mean of relative unit ± SEM of six to nine cultures with the
control animals having a value of 1, with each sample processed in duplicate.
*p < 0.05, **p < 0.01, ***p < 0.001 versus corresponding control value in the
paired Student’s t-test.
FIG. 5. Testosterone secretion by E18.5 testes cultured in the presence of
oLH or db-cAMP and in the absence (white bars) or presence (black bars) of
200lM MEHP. Values are mean ± SEM of testosterone secretion on day 3
of culture (n ¼ 11–18 cultures). **p < 0.01, ***p < 0.001, versus control value
in the paired Student’s t-test.
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number of gonocytes by ~40–50% after 3 days of culture (D3),
that is, 24 h after resuming mitosis and apoptosis. As expected
(Delbes et al., 2004), in testes from E18.5 the number of
gonocytes was higher in ERb/ mice than in wild-type mice
(ERbþ/þ) after 3 days of culture. After MEHP treatment, the
number of gonocytes was reduced in the same manner in E18.5
testes from wild-type mice and from ERb/ or Tfm mice
(Fig. 8). Taken together, these results demonstrate that MEHP
reduces the number of germ cells throughout fetal/neonatal life
except during the quiescent period, independently of the level of
testosterone production and of ER and AR pathways.
Germ cell proliferation and apoptosis. The decrease in the
number of gonocytes in MEHP-exposed testes could be
induced by an increased rate of apoptosis or by a reduced rate
of proliferation. The effect of MEHP on proliferation and
apoptosis was therefore studied by assessing the percentage of
BrdU (Fig. 7D) and cleaved caspase 3–positive (Fig. 7C)
gonocytes, respectively.
MEHP greatly increased the rate of apoptotic gonocytes at
all the ages studied (Fig. 7C). At the same time, the
proliferation of the gonocytes was increased by 40% in
E13.5 after 24-h exposure to 20lM MEHP (Fig. 7D), but was
reduced by 60% in E18.5 testes after 3 days of exposure to
200lM MEHP. Taken together, these results show that MEHP
reduces the number of gonocytes essentially by increasing
apoptosis.
DISCUSSION
We have previously shown that ER and AR are involved in
fetal testis development (Delbes et al., 2004, 2005; Merlet
et al., 2007). Using an organotypic culture system of fetal testis
from wild-type mice or from mice deficient for ER or AR, we
present here the first demonstration that phthalate-induced
alterations of both steroidogenesis and germ cell number do not
involve ER and AR.
Steroidogenesis
Our findings show that testicular alteration of steroidogen-
esis by phthalates during fetal life is very complex. We report
here for the first time a stimulatory effect of MEHP on
testosterone production in fetal mouse testis and that MEHP
can stimulate, inhibit or have no effect on testosterone
production depending on the age of the testis at explantation
and on the culture conditions. These results differ from those of
numerous experiments conducted in the rat that have led to the
conclusion that the main deleterious effect of phthalates
concerns their antiandrogenic capacity, because testosterone
production by the fetal testis is reduced after in utero (Fisher
et al., 2003; Foster, 2006) or in vitro exposure (Chauvigne´
et al., 2009; Hallmark et al., 2007) to phthalates. Furthermore,
recent experiments on in utero exposure to DBP in the mouse
(Gaido et al., 2007) and on in vitro exposure of fetal human
testis to MBP (Hallmark et al., 2007) or MEHP (Lambrot et al.,
2009) failed to observe any inhibition of testosterone pro-
duction or changes in the expression of the steroidogenic
enzymes. Moreover, phthalates can stimulate steroidogenesis in
prepubertal testis in vivo (Lin et al., 2008), in mouse gonadal
cell lines or primary Leydig cell cultures (Ge et al., 2007). In
all these cases, the mechanisms involved have not been fully
elucidated.
In the present study, the MEHP-induced stimulation of
steroidogenesis can be ascribed mainly to an increased
FIG. 6. AMH immunostaining in mouse testes at E13.5 (A, D), E15.5 (B, E), E18.5 (C, F) cultured for 3 days in control medium (A, B, C) or in the presence
of 200lM MEHP (D, E, F). Black arrow: mononucleated gonocyte; orange arrow: MNGs; arrowhead: Sertoli cell.
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transcription of p450C17 and also of HMGCoA-reductase, as
reported in gonadal cell lines (Gunnarsson et al., 2008) or of
StAR, depending on the developmental stage. In contrast, the
inhibitory effect of MEHP on steroidogenesis was obtained by
a reduction of the level of the mRNAs of the main genes
involved in testosterone biosynthesis while, in the rat it was
mainly ascribed to p450C17 and P450scc (Chauvigne´ et al.,
2009; Culty et al., 2008; Hallmark et al., 2007). Additionally,
in E18.5 testes, MEHP reduced the expression of LH-R, but
this does not seem to be involved in the reduction of
steroidogenesis. The reduction of aromatase activity could
participate in the stimulation of testosterone production in the
absence of LH, that is, in conditions of low testosterone
production, mostly by reducing the inhibition of steroidogen-
esis by estradiol (Delbes et al., 2006, 2007) via ERa (Delbes
et al., 2005), the reduction of testosterone transformation being
probably negligible because intratesticular estradiol concentra-
tion is very low (Delbes et al., 2004). However, we show here
that the ERa pathway (Delbes et al., 2006) is involved neither
in the stimulatory nor in the inhibitory effects of MEHP on
testosterone secretion.
The present results provide new insights into the mecha-
nisms underlying the effects of phthalates on fetal testicular
steroidogenesis, because they prove that they are independent
of the ER pathway but depend on other factors: 1) the
developmental stage, which modulates the maturation and the
limiting steps of the steroidogenic pathway, the LH level and
the cholesterol availability (present results; Gunnarsson et al.,
2008; Hallmark et al., 2007); 2) the species because, in vitro,
unlike the rat (Chauvigne´ et al., 2009) and the results we
present here in the mouse, human fetal testis is not sensitive to
phthalate in terms of steroidogenesis (Hallmark et al., 2007;
Lambrot et al., 2009). Aggregation of Leydig cells and even
their presence in the seminiferous tubules have also been
reported to be a prominent consequence of in utero (Lin et al.,
2008; Mahood et al., 2005) or in vitro (Chauvigne´ et al., 2009;
Hallmark et al., 2007) exposure of rat fetal testis to phthalates,
but was not observed in the present experiments on mouse
testis in vitro or in vivo (Gaido et al., 2007) or in human fetal
testis in vitro (Hallmark et al., 2007; Lambrot et al., 2009).
The importance of an alteration of Leydig cell status during
fetal life is related to its possible role in inducing
FIG. 7. Effect of MEHP on the development of the gonocytes in fetal testes in organ culture. Testes were cultured for 1 day (D1) or 3 days (D3) at E13.5 and
3 days at E15.5 and E18.5 in control medium (white bars) or in the presence of 20lM (gray bars) or 200lM (black bars) MEHP and in the presence or absence of
100 ng/ml oLH as indicated. At the end of the culture, MNGs (A) and total gonocytes (B) were counted as described in Material and Methods. The percentage of
cleaved caspase-3–positive gonocytes (C) was used to measure apoptotic activity and the percentage of BrdU-positive gonocytes (D) to evaluate proliferating
index. Values are mean ± SEM from four to nine cultures. *p < 0.05, **p < 0.01, ***p < 0.001 versus corresponding control value in the paired Student’s t-test.
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cryptorchidism and hypospadia (Foster et al., 2001; Henley
and Korach, 2006) and concerns not only testosterone but also
Insl3 production. Underdeveloped gubernaculum (Barlow and
Foster, 2003) and reduced Insl3 expression have been
observed following fetal exposure to phthalates in male rats
(Lague and Tremblay, 2008; Lehmann et al., 2004;
McKinnell et al., 2005). Indeed, Insl3 mRNA was also
reduced in the mouse testes after MEHP exposure, except in
E13.5 testis in basal conditions when maturation/stimulation
of Leydig cells is low.
Gonocyte Development
Our findings clearly show that phthalates strongly impair
germ cell development in the fetal mouse testis in vitro during
critical time-specific windows. In our model, MEHP reduces
the number of gonocytes by inducing massive apoptosis
during early fetal and late fetal/neonatal life, in relation to the
high mitotic and apoptotic activity during these periods.
During the quiescent phase between E15.5 and E19.5 (day of
birth), due to the naturally low apoptotic activity of the
gonocytes, phthalates did not significantly reduce their
number. This can be compared with the low sensitivity to
retinoic acid (Livera et al., 2000) and transforming growth
factor (TGFb1) (Olaso et al., 1998) of rat germ cells during
their quiescent period. These results are in accordance with
the few studies that have previously focused on the
modification of the number of gonocytes by phthalates in
other species, with the mouse being particularly sensitive: in
the rat in vivo, the number of gonocytes is reduced at E21.5
when the animals are treated from E13.5, but not when they
are treated later (Ferrara et al., 2006); in vitro MEHP reduces
the number of gonocytes in the fetal testis of E14.5
(Chauvigne´ et al., 2009) and of PN3 neonate (Li and Kim,
2003); lastly, phthalates have been shown recently to reduce
the number of gonocytes in human fetal testis in vitro at an
early stage (Lambrot et al., 2009).
Apoptosis could result from a direct effect of phthalates on
the gonocytes or from an indirect effect via other cell types.
The fact that the deleterious effects of MEHP on the gonocytes
are similar whether it stimulates or inhibits steroidogenesis
suggests that they do not involve antiandrogenic effects as
postulated in the rat (Chauvigne´ et al., 2009; Scott et al., 2007;
Skakkebaek et al., 2001). This hypothesis was strengthened by
the fact that MEHP reduces the number of gonocytes in
a similar fashion in Tfm mice. The gonocytes of ERbKO mice
were also similarly affected, demonstrating that MEHP does
not also act via ER, directly, or indirectly via the modulation of
aromatase. Therefore, even though we demonstrated previously
that ERb and AR pathways physiologically control fetal germ
cell number (Delbes et al., 2004; Merlet et al., 2007), we can
definitively eliminate a direct or indirect effect of MEHP on
fetal germ cells via antiandrogenic/estrogenic effects.
In the rat, germ cell apoptosis could also be induced by
Sertoli cells (Fisher et al., 2003; Kleymenova et al., 2005)
which are targets of MEHP because, although their pro-
liferation is not affected, they exhibit a reduction in AMH
content. Various nonexclusive pathways have been postulated
to be involved in MEHP-induced germ cell apoptosis, such as
the TRAIL (McKee et al., 2006) and NF-kB (Rasoulpour and
Boekelheide, 2005) pathways and the Fas/FasL system
(Giammona et al., 2002; Yao et al., 2008). Lastly, our in vitro
observations in the mouse that phthalates disturb gonocyte
migration and increase the occurrence of MNGs in late fetal life
are in agreement with in vivo observations in the mouse (Gaido
et al., 2007) and rat (Ferrara et al., 2006; Kleymenova et al.,
2005).
The phthalate-induced alteration in the number of gonocytes
at the fetal and neonatal stage could compromise subsequent
reactivation of germ cell proliferation and development during
puberty as in the rat (Ferrara et al., 2006) and lead to altered
fertility in adulthood. Furthermore, the impairment of differ-
entiation of gonocytes is to some extent reminiscent of the
failure of fetal gonocyte differentiation that is thought to lead to
formation of CIS (carcinoma in situ) cells and subsequent
testicular germ cell tumors in humans (Rajpert-De Meyts,
2006). Further studies are needed to establish if in utero
exposure to phthalates leads, in the mouse, to altered fertility or
occurrence of tumors in adulthood.
CONCLUSION
The present data define specific critical periods of sensitivity
of fetal mouse testis to MEHP and clearly establish that the
effects of phthalates on steroidogenesis are unrelated to those
on gonocyte development. We demonstrated that the strong
deleterious effect of phthalates on the germ cell lineage that is
observed in various mammalian species is independent of any
FIG. 8. Involvement of ER and AR in the effects of MEHP on the number
of gonocytes in fetal testes. Testes at E18.5 from wild-type, ERb/ and Tfm
mice were cultured for 3 days in control medium (white bars) or in the presence
of 200lM MEHP (black bars). At the end of the culture, total gonocytes were
counted as described in Material and Methods. Values are mean ± SEM from
four to nine cultures. *p < 0.05, **p < 0.01 versus corresponding control value
in the paired Student’s t- test for wild-type mice; p < 0.05 in the unpaired
Student’s t-test for two different genotypes.
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antiandrogenic effects and that the phthalates are neither
estrogenic nor antiandrogenic because their effects do not
involve, directly or indirectly, ER or AR.
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